BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25262763)

  • 1. Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity.
    Cassar S; Teede HJ; Harrison CL; Joham AE; Moran LJ; Stepto NK
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):50-8. PubMed ID: 25262763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome.
    Chen CI; Hsu MI; Lin SH; Chang YC; Hsu CS; Tzeng CR
    Gynecol Endocrinol; 2015 Apr; 31(4):264-8. PubMed ID: 25423261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
    Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
    Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of Selected Adipokines and Factors Regulating Carbohydrate Metabolism in Patients with Head and Neck Cancer in Respect to Their Body Mass Index.
    Nuszkiewicz J; Czuczejko J; Dróżdż W; Woźniak A; Małkowski B; Szewczyk-Golec K
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin levels in polycystic ovary syndrome.
    Vrbikova J; Hill M; Bendlova B; Grimmichova T; Dvorakova K; Vondra K; Pacini G
    Eur J Endocrinol; 2008 Aug; 159(2):121-7. PubMed ID: 18511472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome.
    Chang CL; Huang SY; Soong YK; Cheng PJ; Wang CJ; Liang IT
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2539-48. PubMed ID: 25029417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
    Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A
    Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Levels of Ghrelin, Glucagon, Visfatin and Glp-1 Are Decreased in the Peritoneal Fluid of Women with Endometriosis along with the Increased Expression of the CD10 Protease by the Macrophages.
    Krasnyi AM; Sadekova AA; Smolnova TY; Chursin VV; Buralkina NA; Chuprynin VD; Yarotskaya E; Pavlovich SV; Sukhikh GT
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome.
    Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Endocr J; 2013; 60(9):1107-13. PubMed ID: 23801024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study.
    Majuri A; Santaniemi M; Rautio K; Kunnari A; Vartiainen J; Ruokonen A; Kesäniemi YA; Tapanainen JS; Ukkola O; Morin-Papunen L
    Eur J Endocrinol; 2007 Feb; 156(2):263-9. PubMed ID: 17287417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
    Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.
    Teede H; Ng S; Hedger M; Moran L
    Metabolism; 2013 Oct; 62(10):1394-400. PubMed ID: 23768911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.